The report analyzed the digital services capabilities of 23 IT service providers to the life sciences sector globally. It highlights TCS' credible digital transformation capabilities with scale and consistency of performance. Also cited as a key strength is the company's focus on next-generation digital solutions such as Advanced Drug Development (ADD) and Connected Clinical Trials leveraging artificial intelligence, smart analytics and IoT for drug development and patient engagement.